Found 7 matching trials
Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck PHASE2 Primary Objective:
To evaluate the overall response rate (including comple...
Show More Location
Multiple Locations
Learn More & Join Trial
Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy PHASE3 This is a prospective, multicenter, open-label, randomized phase III study ...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer PHASE3 The primary objective of the study was to demonstrate overall survival impr...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Feasibility and Safety of Neoadjuvant Chemotherapy (FLOT ) for Gastric Cancer Patients in China N/A Neoadjuvant chemotherapy for advanced-stage gastric cancer is justified by ...
Show More Location
Ruijin Hospital Shanghai Jiaotong University School of Medicine
Learn More & Join Trial
Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer PHASE2 Primary Objective:
* Response rate (by contrast CT scan)
Secondary Object...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer PHASE3 RATIONALE: Androgens can cause the growth of prostate cancer cells. Hormone...
Show More Location
UAB Comprehensive Cancer Center
Learn More & Join Trial
A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies PHASE1 This is a Phase 1, open-label, multicenter study of continuous oral dosing ...
Show More Learn More & Join Trial